_:n0859d9e789ca4923a328a5ab3ce6bf87xb4
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://alzheon.com/alzheon-reports-industry-leading-biomarker-brain-preservation-and-clinical-effects-following-12-months-of-treatment-in-phase-2-trial-of-oral-alz-801-valiltramiprosate-in-patients-with-early-alzheim/>